Cargando…
Does Drug-Resistant Extrapulmonary Tuberculosis Hinder TB Elimination Plans? A Case from Delhi, India
Extrapulmonary drug-resistant tuberculosis (DR-EPTB) poses a formidable diagnostic and therapeutic challenge.Besides associated with high morbidity, it is a major financial burden for the patient and the health system. In spite of this, it has often been neglected as it does not “pose” a visible pub...
Autores principales: | Lohiya, Sheelu, Tripathy, Jaya Prasad, Sagili, Karuna, Khanna, Vishal, Kumar, Ravinder, Ojha, Arun, Bhatnagar, Anuj, Khanna, Ashwani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558170/ https://www.ncbi.nlm.nih.gov/pubmed/32630163 http://dx.doi.org/10.3390/tropicalmed5030109 |
Ejemplares similares
-
National TB elimination programme - What has changed
por: Khanna, Ashwani, et al.
Publicado: (2023) -
Diabetes care in public health facilities in India: a situational analysis using a mixed methods approach
por: Tripathy, Jaya Prasad, et al.
Publicado: (2019) -
“DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India
por: Vatsyayan, Vindhya, et al.
Publicado: (2022) -
Diagnostic performance of non-invasive, stool-based molecular assays in patients with paucibacillary tuberculosis
por: Gaur, Mohita, et al.
Publicado: (2020) -
Developing a model to predict unfavourable treatment outcomes in patients with tuberculosis and human immunodeficiency virus co-infection in Delhi, India
por: Madan, Chandravali, et al.
Publicado: (2018)